Sunwin Stevia International, Inc. Reports Earnings Results for the Third Quarter Ended January 31, 2020
March 16, 2020 at 01:49 pm EDT
Share
Sunwin Stevia International, Inc. announced earnings results for the third quarter ended January 31, 2020. For the third quarter, the company announced total revenue was USD 5.203 million compared to USD 5.648 million a year ago. Operating loss was USD 960,369 compared to USD 809,692 a year ago. Net loss was USD 1.181 million compared to USD 1.018 million a year ago. Basic loss per share was USD 0.01 compared to USD 0.01 a year ago. For the nine months, total revenue was USD 19.255 million compared to USD 15.531 million a year ago. Operating loss was USD 571,975 compared to USD 2.591 million a year ago. Net loss was USD 1.373 million compared to USD 3.314 million a year ago. Basic loss per share was USD 0.01 compared to USD 0.02 a year ago.
Sunwin Stevia International, Inc. sells stevioside, a natural sweetener, and herbs used in traditional Chinese medicines and veterinary products. The Company operates through two segments related to its product lines: Stevioside, which produces and sells a range of purified steviol glycosides with rebaudioside A and stevioside as the principal components; a natural, low calorie sweetener, and OnlySweet, a stevioside-based table top sweetener, and Chinese medicines, which manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by both humans and animals. The Company engages in new product development both through its internal research facilities, industry consultants and specialists to provide research and development for the planting of stevia plants, for the development of biological methods to improve lower-grade stevia product to higher-grade stevia, and for the application of biological method to change the taste of stevia.
SUNWIN STEVIA INTERNATIONAL, INC. 
